In contrast to microphages without TCC treatment, macrophages treated with TCC in vitro exhibited significantly better inflammatory activation parameters, including the levels of iNOS, COX-2, IL-6, and TNF-α, and increased survival by 83% (Table 2) [88]. Here, IL6 is linked to tarsal-carpal coalition syndrome.